GEN Exclusives

More »

GEN News Highlights

More »
Sep 10, 2007

GenVec to Develop Malaria Vaccine for the U.S. Military

  • GenVec entered into a CRADA with the U.S. Military Malaria Vaccine Program for the development and preclinical testing of a malaria vaccine candidate against Plasmodium vivax (P. vivax). Partners include Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center.

    In addition to the CRADA, GenVec has signed a one-year contract with the DoD to construct and test the adenovector-based vaccine, which carries a novel antigen against P. vivax developed by WRAIR scientists. GenVec and its collaborators will jointly design preclinical studies to evaluate the immunogenicity of the adenovector and WRAIR’s recombinant sub-unit vaccine in various combination prime/boost vaccination strategies.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »